Spike Neutralizing Antibody (Clone G10xA1) (SARS-CoV-2)
This monoclonal antibody recognizes the SARS-CoV-2 Spike (B.1.1.529, Omicron Variant) RBD Domain and the S1+S2 trimeric complex to neutralize its interaction with ACE2 [Table of variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) :ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience #78339) .
Product Specifications
Applications
Purification
Protein A affinity chromatography
Format
Aqueous buffer solution
Shipping Conditions
-20°C (Gel Packs or Dry Ice)
Storage Conditions
Store in aliquots at -20°C. Stable for at least 6 months from date of receipt.
Calculated Molecular Weight
~150 kDa
Specificity
Formulation
1x PBS, 0.2% BSA
CAS Number
9007-83-4
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DTL (Denticleless Protein Homolog, DDB1-and CUL4-associated Factor 2, Lethal(2) Denticleless Protein Homolog, Retinoic Acid-regulated Nuclear Matrix-associated Protein, CDT2, CDW1, DCAF2, L2DTL, RAMP) (AP)
DTL (Denticleless Protein Homolog, DDB1-and CUL4-associated Factor 2, Lethal(2) Denticleless Protein Homolog, Retinoic Acid-regulated Nuclear Matrix-associated Protein, CDT2, CDW1, DCAF2, L2DTL, RAMP) (AP)